Don't Recommend Baxdela to Treat Most Skin Infections

November 2017

Baxdela (baks-DEH-lah, delafloxacin) is a new quinolone antibiotic.

So far it's only approved to treat skin infections.

It seems to have better coverage than other quinolones for gram-positive bacteria...including methicillin-resistant Staph aureus (MRSA).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote